Sigma Healthcare Supports Growth by Automating Operations at its new Perth & Brisbane Distribution Centres with Dematic
July 19, 2021
After the successful deployment of the Dematic solution, Sigma is set to host a virtual tour of its Brisbane facility
SYDNEY — As part of its network optimisation strategy to increase its competitiveness in the pharmaceutical industry, leading Australian pharmaceutical wholesaler, Sigma Healthcare, has automated operations at its new Perth and Brisbane distribution centres (DCs) with the Dematic Goods-to-Person (GTP) Picking Solution.
Sigma selected the fully-automated Dematic solution as the central system to improve operational efficiencies at its two new DCs in Perth and Brisbane. Sigma’s switch to automation stemmed from previous supply chain challenges experienced from legacy systems deployed at other DCs, which were restricting the ability to continue to improve service delivery to customers.
“Warehouse and logistics have been an area of significant focus for Sigma over the past three years. With the pharmaceutical market as competitive as it is in Australia, it was clear that we needed to optimise these two new DCs to accommodate current and future demands on our supply chain,” said Paul Brown, National Operations Manager, Logistics, Sigma.
The system is an automated picking and buffering sequence solution, meaning orders are picked, buffered, and then sequenced to delivery vehicles in the specific order required. For Sigma, this process works to optimise the entire picking and delivery process by organising orders accurately and efficiently, and at a much faster rate than manual operations.
“By optimising these new DCs through automation, it was clear that this kind of technology was a natural step forward for Sigma as a business. Pharmacies are constantly pushing Sigma as their sole distributor for increased service levels, which were just not achievable at previous operation rates. By initiating a more innovative approach to picking operations, we can make the most of our two new DCs with advanced automation technologies ensuring the highest efficiency,” added Paul.
Through the deployment of the Dematic GTP Solution, Sigma has subsequently made significant progress to its initiated business transformation program (Project Pivot), which aims to deliver $100+ million in efficiency gains by the end of the 2021 financial year.
The Dematic solution is uniquely attuned to the pharmaceutical conditions of Sigma’s DCs, with the system able to operate in a temperature-controlled environment, which is required for select pharmaceutical products that must be stored between 2° and 8°C.
“An essential part of this solution’s design was for it to be able to cater for Sigma’s distinctive storage requirements. For example, there are some products that require refrigeration and others that need to be stored in a vault or highly secured environment – with both having a lot of regulations around them, “said Darren Rawlinson, Regional Solutions Development Director, APAC, at Dematic. “By understanding the requirements of the products within the DCs, our solution cohesively combines its automation capabilities with the existing infrastructure of the DCs, which effectively boosts overall productivity without the risk of product damage.”
With the integration of an advanced automated goods-to-person picking system, Dematic helped Sigma achieve high operational efficiency and accuracy rates, as well as improve its service and delivery levels to meet customer needs.
Sigma and Dematic will host a virtual tour of the automated DC in Brisbane on August 4 to provide more insight into the automation project. Click here to register for the virtual event tour.
Hosted by Paul Brown, National Operations Manager, Logistics for Sigma, and Pas Tomasiello, Senior Regional Director – Sales & Solutions Development at Dematic, the virtual tour will walk you through a 360° video tour of the facility in action, taking a closer look at the technologies and subsystems that are proving to be a prescription for success in the Australian pharmaceutical supply chain.
About Sigma Healthcare
Sigma Healthcare is a leading Australian full line wholesale and distribution business catering to community and hospital pharmacies. Employing over 1,100 team members, Sigma services over 4,000 pharmacies and operates 10 distribution centres (DCs) nationwide. Sigma has one of the largest pharmacy networks in Australia, with over 1,200 branded and independent pharmacies, including some of Australia’s best known pharmacy retail brands such as Amcal, Guardian, Pharmasave, Chemist King, WholeLife, and Discount Drug Stores, which collectively account for close to 20% of consumer spend in pharmacy in Australia.
Dematic designs, builds, and supports intelligent automated solutions empowering and sustaining the future of commerce for its customers in manufacturing, warehousing, and distribution. With research and development engineering centers, manufacturing facilities, and service centers located in more than 35 countries, the Dematic global network of over 11,000 employees has helped achieve approximately 8,000 worldwide customer installations for some of the world’s leading brands. Headquartered in Atlanta, Dematic is a member of KION Group, one of the world’s leading suppliers of industrial trucks and supply chain solutions.
This release and the information contained herein are for information purposes only and do not constitute a prospectus or an offer to sell or a solicitation of an offer to buy any securities in the United States or in any other jurisdiction. This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, for example, changes in business, economic, and competitive conditions (including with respect to further developments in relation to the COVID-19 pandemic), regulatory reforms, results of technical studies, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. We do not undertake any responsibility to update the forward-looking statements in this release.